Parsian Pharmaceutical Company was established in 2009 in Avicenna National Biotechnology Park with the aim of meeting the domestic market need for high-tech Active Pharmaceutical Ingredients (API) by relying on collaborative knowledge and hands-on experience of accomplished scientific members of pharmaceutical department of University of Tehran. By adopting cutting-edge technologies and accurate strategies in various facets of providing affordable API’s for meeting domestic needs, Parsian Pharmaceutical company has turned into one of the most credible rock stones for each and every one of the pharmaceutical companies seeking for API’s synthesized by high-end facilities and broad range of knowledge behind the process. In 2015, Parsian Pharmaceutical Company succeeded was granted two invaluable certificates—namely GMP Export and GMP Production Certificate—from Food and Drug Administration of Iran, based on its visions and missions. Previously mentioned certificates led to make our complex the most significant site manufacturing hazardous API’s throughout Iran. As the major vision of the company, that is offering wide variety of products and API’s to the market of pharmaceutical ingredients and Granules, is of high significance to each and every one endeavoring to reach that mission, the company has more than 20 active projects in the Research and Development and analysis phase to be investigated and industrialized, which will be launched to the country’s market based on priorities and needs after meeting the necessary standards.
